Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 7/20 | 0.40 |
| ▸ | MAOA | P21397 | 4/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 5/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5275595 | 0.93 | MAOB (0.39) | KIF11MAOBMAOAADRA2AGABRB3 | |
| SCHEMBL22587363 | 0.83 | ADRA2A (0.49) | KIF11MAOBMAOAADRA2AGABRB3 | |
| SCHEMBL31751941 | 0.82 | KIF11 (0.50) | KIF11ALDH1A1TSHRPDK2 | |
| SCHEMBL30970983 | 0.80 | KIF11 (0.61) | KIF11ADRA2AGABRB3GABRA1GABRG2 | |
| SCHEMBL20336329 | 0.80 | KIF11 (0.61) | KIF11ADRA2AGABRB3GABRA1GABRG2 | |
| SCHEMBL23860299 | 0.76 | KIF11 (0.45) | KIF11ADRA2AGABRB3GABRA1GABRG2 | |
| SCHEMBL20261725 | 0.76 | KIF11 (0.45) | KIF11ADRA2AGABRB3GABRA1GABRG2 | |
| SCHEMBL22587365 | 0.76 | KIF11 (0.45) | KIF11MAOBMAOAADRA2AGABRB3 | |
| SCHEMBL14655026 | 0.76 | KIF11 (0.49) | KIF11ADRA2AGABRB3GABRA1GABRG2 | |
| SCHEMBL13619662 | 0.76 | KIF11 (0.45) | KIF11MAOBMAOAADRA2AGABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731603-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SuSoS AG (CH) | 2026-04-29 | — | — | EP | claimed |
| WO-2025095666-A1 | NOVEL OXOCYANINE-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 포항공과대학교 산학협력단 | 2025-05-08 | — | — | WO | claimed |
| WO-2024261308-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SUSOS AG (CH) | 2024-12-26 | — | — | WO | claimed |
| US-20210231677-A1 | TRACELESS IMMOBILIZATION OF ANALYTES FOR SAMDI MASS SPECTROMETRY | NORTHWESTERN UNIVERSITY | 2021-07-29 | — | — | US | claimed |
| WO-2019237019-A9 | TRACELESS IMMOBILIZATION OF ANALYTES FOR SAMDI MASS SPECTROMETRY | NORTHWESTERN UNIVERSITY (US) | 2020-06-11 | — | — | WO | claimed |
| US-10551388-B2 | Method of determining a protein in a sample | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) | 2020-02-04 | — | — | US | claimed |
| EP-2877857-B1 | METHOD OF DETERMINING A PROTEIN IN A SAMPLE | UNIV BONN RHEINISCHE FRIEDRICH WILHELMS (DE) | 2019-03-13 | — | — | EP | claimed |
| US-10005936-B2 | Photoactive bioadhesive compositions | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-06-26 | — | — | US | claimed |
| US-20180143201-A1 | METHOD OF DETERMINING A PROTEIN IN A SAMPLE | CARIS MPI, INC. | 2018-05-24 | — | — | US | claimed |
| US-9910045-B2 | Method of determining a protein in a sample | RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITAT BONN (DE) | 2018-03-06 | — | — | US | claimed |
| WO-2015031265-A1 | CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS | SURMODICS, INC. (US) | 2015-03-05 | — | — | WO | claimed |
| WO-2014016368-A1 | METHOD OF DETERMINING A PROTEIN IN A SAMPLE | RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONN (DE) | 2014-01-30 | — | — | WO | claimed |
| EP-2690441-A1 | Method of determining a protein in a sample | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2014-01-29 | — | — | EP | claimed |
| US-20100226938-A1 | Cellular and viral inactivation | HEALTH AND HUMAN SERVICES, GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF | 2010-09-09 | — | — | US | claimed |
| US-20090297558-A1 | Inactivated Influenza Virus Compositions | DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH, GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2009-12-03 | — | — | US | claimed |
| WO-2008054481-A2 | IMPROVED INACTIVATED INFLUENZA VIRUS COMPOSITIONS | GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH (US) | 2008-05-08 | — | — | WO | claimed |
| CN-1954066-A | Cellular and viral inactivation | US GOVERNMENT (US) | 2007-04-25 | — | — | CN | claimed |
| US-7084285-B2 | Photoaffinity-labeled sphingomyelin analogs and processes thereof | DAISO CO., LTD. (JP) | 2006-08-01 | — | — | US | claimed |
| US-20030013696-A1 | Methods and compositions for photo-cross linking photoactive compounds to target tissue | BRITISH COLUMBIA, UNIVERSITY OF, THE (CA) | 2003-01-16 | — | — | US | claimed |
| WO-2002076453-A1 | METHODS AND COMPOSITIONS FOR PHOTO-CROSS LINKING PHOTOACTIVE COMPOUNDS TO TARGET TISSUE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-10-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10005936-B2 | Photoactive bioadhesive compositions | L1CAM, CDH1, PCNA | KIF11 2656/4885MAOB 1751/4885MAOA 949/4885 |
| US-20090297558-A1 | Inactivated Influenza Virus Compositions | ITPA, IDO1, IDE | KIF11 1689/4885MAOB 839/4885MAOA 401/4885 |
| US-20100226938-A1 | Cellular and viral inactivation | TP53, IFNG, POLI | KIF11 2536/4885MAOB 2407/4885MAOA 2292/4885 |
| US-20030013696-A1 | Methods and compositions for photo-cross linking photoactive compounds to target tissue | LCP1, PPOX, TYR | KIF11 4114/4885MAOB 474/4885MAOA 704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.